Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Bayer AG : Bayer CropScience Expands Research and Development Cooperation with Nature Source Genetics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/14/2013 | 03:33pm CET

Bayer%20CropScience%20Expands%20Research%20and%20Development%20Cooperation%20with%20Nature%20Source%20Genetics%20');openNewWindow('../ID_Image/FB05CAE5FD58303DC1257B2E0036C933?Open&l=EN#download',500,525,0,0,'scrollbars=yes,resizable=yes,statusbar=no');return false;" href="../ID_Image/FB05CAE5FD58303DC1257B2E0036C933?Open&l=EN#download" sizset="false" sizcache02840271716677351="0.0.10"downloadSoybean plants

Monheim (Germany) and Ithaca (USA), March 14, 2013- Bayer CropScience and the research company Nature Source Genetics, based in Ithaca, New York, USA, have signed an agreement to expand their already fruitful cooperation. They have entered into a five-year collaboration involving the pre-breeding and enhancement of soybean germplasm. The goal is to create improved seed by making use of innovative technologies to identify and incorporate previously non detectable, naturally occurring genes. Financial terms have not been disclosed.

The partnership will combine the expertise of Bayer CropScience's soybean breeders and geneticists with Nature Source Genetics' technical know-how and the company's bioanalytical platform to identify and utilize the full range of promising germplasm. The partnership also builds on a successful cotton partnership, which began in 2008.

"The collaboration between Bayer CropScience and Nature Source Genetics marks a significant expansion in the strategic scope of our soybean breeding program", said Mike Gilbert, Head of Global Breeding and Trait Development at Bayer CropScience. "With this partnership, we now have access to new and valuable sources of genetic diversity in soybeans, which we can incorporate into our already robust breeding program to further expand and improve the products we offer growers worldwide."

This agreement will provide Bayer CropScience researchers with the opportunity to identify high value genes in previously unused genetic material and incorporate these new genes into commercial germplasm.

"We are very pleased to be entering into this joint venture with Bayer CropScience for the genetic improvement of soy. Nature Source Genetics brings to this partnership unique expertise and proprietary algorithms developed within its bioanalytical platform encompassing diverse competencies from life and computational sciences," said Professor Steven D. Tanksley, CEO and Chief Scientific Officer of Nature Source Genetics. "These competencies will significantly expedite the identification and incorporation of new and useful genetic variation into Bayer CropScience's breeding material for the development of improved commercial varieties."

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care,
agriculture and high-tech materials. This year the company looks back on 150 years of working to fulfill its mission "Bayer: Science For A Better Life". Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,383 million (2012) and is one of the world's leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 20,800 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

About Nature Source Genetics
Nature Source Genetics is a company based in Ithaca, New York co-founded in 2006 by Professor Steven D. Tanksley and Dr. Theresa M. Fulton from Cornell University with Dr. Vincent Pétiard, the former Head of Plant Sciences and Technology at Nestlé. Nature Source Genetics offers exclusive services on a crop per crop basis, and is currently working on different field crops, vegetables, and tropical crops with agro-seed and food companies to optimize the benefits of natural genetic diversity in target crops. Nature Source Genetics has also started to explore with animal breeding companies the opportunities of use of its computational genomics capabilities. More info at: www.naturesourcegenetics.com

Find more information at www.bayercropscience.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
08:05aBAYER AKTIENGESELLSCHAFT : Preliminary announcement of the publication of financ..
EQ
02/19BASF to face millions in extra costs in UK each year from Brexit - Handelsbla..
RE
02/19Rare Haematology Market Trend to 2025 Profiling PRA Health Sciences, Bayer He..
AQ
02/16BAYER : fördert freiwilliges Mitarbeiter-Engagement seit zehn Jahren
PU
02/15BAYER : Researchers Submit Patent Application, "Antibody and Protein Formulation..
AQ
02/15BAYER : Recent Findings in Pesticides Described by Researchers from Bayer (Refin..
AQ
02/15BAYERNPV : Bayer receives first approval for Eylea in China
AQ
02/15BAYER : Syngenta aims to sell bonds within weeks, M&A important - CFO
RE
02/15BAYER : and Mitsui Chemicals Agro sign licence agreement for novel fungicide
PU
02/14BAYER : Gets FDA Warning Over Manufacturing Practices at German Site
DJ
More news
News from SeekingAlpha
02/20Tracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update 
02/16Tracking David Einhorn's Portfolio - Q4 2017 Update 
02/15Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2017 Update 
02/14ROAD TO FINANCIAL INDEPENDENCE : My January 88-Stock Portfolio Review 
02/13Bayer sues Russian antitrust regulator in bid for more time in Monsanto case 
Financials (€)
Sales 2017 35 346 M
EBIT 2017 7 428 M
Net income 2017 6 740 M
Debt 2017 8 806 M
Yield 2017 2,63%
P/E ratio 2017 13,77
P/E ratio 2018 18,23
EV / Sales 2017 2,56x
EV / Sales 2018 2,51x
Capitalization 81 810 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 121 €
Spread / Average Target 22%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Johannes M. Dietsch Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-6.36%100 852
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%224 785
PFIZER-2.84%216 135
ROCHE HOLDING LTD.-9.37%207 160
MERCK AND COMPANY-0.50%153 359